PMC:6988269 / 3417-3933 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T11","span":{"begin":448,"end":456},"obj":"Disease"},{"id":"T12","span":{"begin":448,"end":452},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"In the present case of 2019-nCoV, virus isolates or samples from infected patients have so far not become available to the international public health community. We report here on the establishment and validation of a diagnostic workflow for 2019-nCoV screening and specific confirmation, designed in absence of available virus isolates or original patient specimens. Design and validation were enabled by the close genetic relatedness to the 2003 SARS-CoV, and aided by the use of synthetic nucleic acid technology."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T30","span":{"begin":34,"end":39},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T31","span":{"begin":216,"end":217},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T32","span":{"begin":322,"end":327},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"In the present case of 2019-nCoV, virus isolates or samples from infected patients have so far not become available to the international public health community. We report here on the establishment and validation of a diagnostic workflow for 2019-nCoV screening and specific confirmation, designed in absence of available virus isolates or original patient specimens. Design and validation were enabled by the close genetic relatedness to the 2003 SARS-CoV, and aided by the use of synthetic nucleic acid technology."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":492,"end":504},"obj":"Chemical"},{"id":"T4","span":{"begin":500,"end":504},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"}],"text":"In the present case of 2019-nCoV, virus isolates or samples from infected patients have so far not become available to the international public health community. We report here on the establishment and validation of a diagnostic workflow for 2019-nCoV screening and specific confirmation, designed in absence of available virus isolates or original patient specimens. Design and validation were enabled by the close genetic relatedness to the 2003 SARS-CoV, and aided by the use of synthetic nucleic acid technology."}

{"project":"LitCovid-sentences","denotations":[{"id":"T28","span":{"begin":0,"end":161},"obj":"Sentence"},{"id":"T29","span":{"begin":162,"end":367},"obj":"Sentence"},{"id":"T30","span":{"begin":368,"end":516},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In the present case of 2019-nCoV, virus isolates or samples from infected patients have so far not become available to the international public health community. We report here on the establishment and validation of a diagnostic workflow for 2019-nCoV screening and specific confirmation, designed in absence of available virus isolates or original patient specimens. Design and validation were enabled by the close genetic relatedness to the 2003 SARS-CoV, and aided by the use of synthetic nucleic acid technology."}

{"project":"LitCovid-PubTator","denotations":[{"id":"63","span":{"begin":23,"end":32},"obj":"Species"},{"id":"64","span":{"begin":74,"end":82},"obj":"Species"},{"id":"65","span":{"begin":242,"end":251},"obj":"Species"},{"id":"66","span":{"begin":349,"end":356},"obj":"Species"},{"id":"67","span":{"begin":448,"end":456},"obj":"Species"},{"id":"68","span":{"begin":482,"end":491},"obj":"Species"},{"id":"69","span":{"begin":65,"end":73},"obj":"Disease"}],"attributes":[{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"Tax:2697049"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"Tax:9606"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"Tax:2697049"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"Tax:9606"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"Tax:694009"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"Tax:2086595"},{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In the present case of 2019-nCoV, virus isolates or samples from infected patients have so far not become available to the international public health community. We report here on the establishment and validation of a diagnostic workflow for 2019-nCoV screening and specific confirmation, designed in absence of available virus isolates or original patient specimens. Design and validation were enabled by the close genetic relatedness to the 2003 SARS-CoV, and aided by the use of synthetic nucleic acid technology."}